Literature DB >> 31664377

Analysis of the cost of care for children and adolescents with medical complex chronic conditions.

Márcia Pinto1, Romeu Gomes1, Roberta Falcão Tanabe1, Ana Carolina Carioca da Costa1, Martha Cristina Nunes Moreira1.   

Abstract

This paper aimed to identify the use of technology and to analyze the cost of hospital care for children and adolescents with medical complex chronic conditions at a public federal hospital specialized in high-complexity pediatric care, and was performed concomitantly with a prospective cohort study conducted over a one-year period. It included 146 patients with complex medical chronic conditions and 37 non-chronic patients. The analysis showed that most patients had, on average, two hospitalizations a year and were diagnosed with diseases related to at least two organic systems. Catheters, drains and gastrostomy were the most common technologies used. Median direct costs of patients with medically complex chronic conditions were higher than those of non-chronic patients when comparing the use of technology. The study shows high hospitalization cost to these patients. Technology use and hospitalization care costs documentation yields more data to support decision-makers in the planning, managing, and financing of pediatric health policies.

Entities:  

Mesh:

Year:  2019        PMID: 31664377     DOI: 10.1590/1413-812320182411.08912018

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  FACTORS ASSOCIATED WITH DE-HOSPITALIZATION OF CHILDREN AND ADOLESCENTS WITH COMPLEX CHRONIC CONDITION.

Authors:  Michelli Christina Magalhães Novais; Deusiane Santos Victor; Danielle da Silva Rodrigues; Bruno Oliveira Freitas; Nilo Manoel Pereira Vieira Barreto; Daiana de Jesus da Silva Mendes; Micheli Bernardone Saquetto
Journal:  Rev Paul Pediatr       Date:  2021-06-23

2.  Impact of children with complex chronic conditions on costs in a tertiary referral hospital.

Authors:  Regina Maria Antunes Mattiello; Antonio Pazin-Filho; Davi Casale Aragon; Palmira Cupo; Ana Paula de Carvalho Panzeri Carlotti
Journal:  Rev Saude Publica       Date:  2022-10-17       Impact factor: 2.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.